Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sphingolipid-renal interplay in coronary artery calcification: ceramide profiling and imaging validation from the CRUISE-MET study.

Created on 29 Oct 2026

Authors

Qiang Chen, Sijia Guo, Xuexi Li, Yike Li, Yingying Xie, Sunjing Fu, Ruoyun Ma, Xiaxia Peng, Sheng Xie, Yanxiang Gao, Jingang Zheng

Published in

Frontiers in endocrinology. Volume 17. Pages 1974775. Epub Oct 14, 2026.

Abstract

Coronary artery calcification (CAC) represents a distinct imaging phenotype reflecting advanced vascular remodeling, particularly in patients with chronic kidney disease (CKD). However, metabolic determinants linking renal dysfunction to CAC remain incompletely understood. Ceramides, bioactive sphingolipids involved in vascular inflammation and calcification, may represent potential mediators of this interaction.
In this cross-sectional analysis of 851 coronary artery disease (CAD) patients from the CRUISE-MET trial (NCT06383208), six plasma ceramide species [Cer(18:1/16:0), (18:1/18:0), (18:1/20:0), (18:1/22:0), (18:1/24:0), and (18:1/24:1)] were quantified by UHPLC-MS/MS. CAC severity was classified angiographically as absent, mild, moderate, or severe. Logistic regression, ROC analysis, and restricted cubic splines assessed associations. Joint and mediation analyses examined interactions with CKD. Sensitivity analyses evaluated consistency across subgroups and in a cohort with non-ECG-gated chest CT-derived CAC scores.
Patients with moderate-to-severe CAC had higher Cer(18:1/16:0), Cer(18:1/24:1), older age, higher SYNTAX scores, and lower estimated glomerular filtration rate (eGFR) (all p<0.05). Each SD increase in Cer(18:1/16:0) was associated with 59% higher odds of moderate-to-severe CAC (OR = 1.59, 95% CI: 1.33-1.88, p<0.001); the highest tertile was associated with 151% higher odds (OR = 2.51, 95% CI: 1.68-3.75, p<0.001). CKD modified this association (p for interaction=0.032), with coexisting CKD and high ceramide exposure yielding nearly fourfold higher odds (OR = 3.94, 95% CI: 2.47-6.28, p<0.001). Mediation analysis indicated Cer(18:1/16:0) accounted for 15.6% of the CKD-CAC association. Associations remained directionally consistent across sensitivity analyses. In the CT subgroup, modest associations were observed between selected ceramide species and quantitative CACS.
Specific ceramides, particularly Cer(18:1/16:0), are independently associated with CAC severity, with stronger associations observed in patients with CKD.

PMID:
42952492
Bibliographic data and abstract were imported from PubMed on 29 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 18
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement